Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Nelson

Showing results (301-310 of 312) with videos related to

Pageof 32
Sort By:
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Journal of the National Cancer Institute|August 12, 2020
Effect of Aspirin on Cancer Incidence and Mortality in Older AdultsJohn J McNeil, Peter Gibbs, Suzanne G Orchard, et al.
American Journal of Hypertension|December 7, 2019
Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional StudyEnayet K Chowdhury, Mark R Nelson, Michael E Ernst, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 23, 2019
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) StudyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 23, 2017
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) StudyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on Disability-free Survival in the Healthy ElderlyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyJohn J McNeil, Mark R Nelson, Robyn L Woods, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
European Heart Journal|August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trialRory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
Pageof 32

Showing results (301-310 of 312) with videos related to

Sort By:
Pageof 32
Contemporary Clinical Trials Communications|November 19, 2020
Baseline characteristics and age-related macular degeneration in participants of the "ASPirin in Reducing Events in the Elderly" (ASPREE)-AMD trialLiubov D Robman, Le Thi Phuong Thao, Robyn H Guymer, et al.
The Medical Journal of Australia|July 11, 2024
National Hypertension Taskforce of Australia: a roadmap to achieve 70% blood pressure control in Australia by 2030Aletta E Schutte, Belinda Bennett, Clara K Chow, et al.
Journal of the National Cancer Institute|August 12, 2020
Effect of Aspirin on Cancer Incidence and Mortality in Older AdultsJohn J McNeil, Peter Gibbs, Suzanne G Orchard, et al.
American Journal of Hypertension|December 7, 2019
Factors Associated With Treatment and Control of Hypertension in a Healthy Elderly Population Free of Cardiovascular Disease: A Cross-sectional StudyEnayet K Chowdhury, Mark R Nelson, Michael E Ernst, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 23, 2019
Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) StudyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|March 23, 2017
Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) StudyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on Disability-free Survival in the Healthy ElderlyJohn J McNeil, Robyn L Woods, Mark R Nelson, et al.
The New England Journal of Medicine|September 18, 2018
Effect of Aspirin on All-Cause Mortality in the Healthy ElderlyJohn J McNeil, Mark R Nelson, Robyn L Woods, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 2, 2020
Medically actionable pathogenic variants in a population of 13,131 healthy elderly individualsPaul Lacaze, Robert Sebra, Moeen Riaz, et al.
European Heart Journal|August 12, 2025
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trialRory Wolfe, Jonathan C Broder, Zhen Zhou, et al.
Pageof 32